Stock ME 23ANDME HOLDING CO.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. 23andMe Holding Co.

Equities

ME

US90138Q1085

Real-time Estimate Cboe BZX
Other stock markets
 12:45:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
0.507 USD -0.59% Intraday chart for 23andMe Holding Co. -0.90% -45.51%
Apr. 24 23andMe Holding Co. to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology Annual Meeting CI
Apr. 23 Petros, Lemonaid Health Collaborate to Expand Stendra Availability MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
23andMe CEO Mulls Plan to Take Company Private
MT
Citigroup Adjusts 23andMe Price Target to $0.47 From $0.85, Maintains Neutral Rating
MT
Citigroup Adjusts 23andMe Holding's Price Target to $1.75 From $2.50, Keeps Buy Rating
MT
Citigroup Adjusts 23andMe Price Target to $2.50 From $3.75, Maintains Neutral Rating
MT
Berenberg Bank Initiates Coverage on 23andMe Holding With Buy Rating, $7 Price Target
MT
Credit Suisse Trims 23andMe Holding's Price Target to $6 From $7, Keeps Outperform Rating
MT
Cowen Initiates Coverage on 23andMe With Outperform Rating, $6 Price Target
MT
Credit Suisse Lowers 23andMe Holding's Price Target to $7 from $11, Notes Near-Term Consumer Volatility; Keeps Outperform Rating
MT
Citigroup Adjusts Price Target on 23andMe to $3 From $6, Maintains Neutral Rating
MT
Credit Suisse Lowers 23andMe Holding's PT to $11 from $14, Trims Revenue Multiple to Reflect Comparable Decline in Comps; Keeps Outperform Rating
MT
Citigroup Adjusts Price Target on 23andMe Holding to $9 From $13, Maintains Neutral Rating
MT
Citigroup Downgrades 23andMe to Neutral From Buy, Adjusts Price Target to $13 From $12
MT
CORRECTION : Credit Suisse Starts 23andMe Holding at Outperform with $13 PT
MT
23andMe : Shares Soar After Credit Suisse Initiates Coverage with Outperform Rating
MT
23ANDME : Credit Suisse Starts 23andMe Holding at Outperform with $31 PT, Sees Optionality for Therapeutics Segment Long Term; Trading Lower Pre-Market
MT
23ANDME : Citigroup Starts 23andMe Holding at Buy with $14 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ME Stock
  4. News 23andMe Holding Co.
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW